Table 1. Clinical, demographic and laboratory baseline characteristics of the study population.
| Variable (unit) | N = 97 |
|---|---|
| Age (years) | 67 ± 9 |
| Male gender | 77 (79) |
| BMI (Kg/cm2) | 27.7 ± 4.0 |
| Hypertension | 80 (82) |
| Dyslipidemia | 65 (67) |
| Diabetes Mellitus type 2 | 37 (38) |
| Insulin treated | 14 (14) |
| Smokers | 61 (63) |
| Clinical presentation | |
| Stable angina | 75 (77) |
| Unstable angina/NSTEMI | 22 (23) |
| Previous MI | 23 (24) |
| Previous PCI | 38 (39) |
| Previous CABG | 4 (4) |
| LVEF (%) | 56 ± 10 |
| FGL (mg/dl) | 101.8 ± 23.2 |
| Creatinine (mg/dl) | 0.94 ± 0.20 |
| CrCl (ml/min) | 87.8 ± 31.7 |
| NGAL (ng/ml) | 99.6 ± 53.1 |
| CK-MB (ng/ml) | 0.8 ± 0.2 |
| Troponin I (ng/ml) | 0.5 ± 4.1 |
Values are indicated as mean ± standard deviation (SD) or n (%). BMI, body mass index; CK-MB, creatine-kinase muscle-brain isoform; CrCl, creatinine clearance; FGL, fasting blood glucose levels; NGAL, neutrophil gelatinase associated lipocalin; NSTEMI, non-ST segment elevation myocardial infarction.